Amino Acid Requirements in TPN for Neonates
Trial Summary
What is the purpose of this trial?
This trial tests how much of three important nutrients newborns need when fed through a tube. It focuses on babies who rely on this type of nutrition and uses a method to see how their bodies use these nutrients.
Will I have to stop taking my current medications?
The trial requires that participants are not on medications known to affect protein and amino acid metabolism. If your current medications affect these, you may need to stop them to participate.
What data supports the effectiveness of the treatment involving Histidine, L-Histidine, Methionine, DL-Methionine, L-Methionine, Phenylalanine, and L-Phenylalanine in TPN for neonates?
Research shows that adjusting amino acid levels in total parenteral nutrition (TPN) can help achieve more normal plasma amino acid patterns in infants, which may improve their overall nutrition and growth. Specifically, studies on phenylalanine and tyrosine in neonatal piglets suggest that understanding and meeting specific amino acid requirements is crucial for effective TPN.12345
How does the treatment of Histidine, Methionine, and Phenylalanine in TPN for neonates differ from other treatments?
This treatment is unique because it focuses on the specific amino acid requirements for neonates receiving total parenteral nutrition (TPN), which are different from those for oral feeding. The study highlights the importance of determining precise amino acid needs, such as phenylalanine, to improve TPN formulations for better nutritional outcomes in neonates.12467
Research Team
Eligibility Criteria
This trial is for stable newborns who are the right size for their age, born at or after 28 weeks of pregnancy, and are under 28 days old. They must be mostly fed through a vein (at least 90% of calories and protein) and not have any infections or serious health issues.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Each baby receives one or two levels of either phenylalanine, methionine, or histidine over a two-day period. Day 1 involves a standard pediatric amino acid solution, and Day 2 involves a TPN Test Solution with the amino acid being investigated.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Histidine (Amino Acid)
- Methionine (Amino Acid)
- Phenylalanine (Amino Acid)
Histidine is already approved in Canada, Japan for the following indications:
- Nutritional supplement in parenteral nutrition
- Nutritional supplement in parenteral nutrition
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Hospital for Sick Children
Lead Sponsor
Dr. Ronald D. Cohn
The Hospital for Sick Children
Chief Executive Officer since 2019
MD from University of Düsseldorf, Germany
Dr. Lennox Huang
The Hospital for Sick Children
Chief Medical Officer since 2016
MD from McGill University